127 related articles for article (PubMed ID: 11853195)
1. Correlation between serum magnesium and blood cyclosporine A concentrations in renal transplant recipients.
Thakur V; Kumar R; Dhawan IK
Ann Clin Biochem; 2002 Jan; 39(Pt 1):70-2. PubMed ID: 11853195
[TBL] [Abstract][Full Text] [Related]
2. Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment.
Allegra A; Corica F; Ientile R; Corsonello A; Sparacino V; Accettola F; Caputo F; Macaione S; Buemi M
Magnes Res; 1998 Mar; 11(1):11-8. PubMed ID: 9595545
[TBL] [Abstract][Full Text] [Related]
3. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
Ahmadi F; Naseri R; Lessan-Pezeshki M
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
[TBL] [Abstract][Full Text] [Related]
4. Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levels.
Ramos EL; Barri YM; Kubilis P; Peterson JC; Pfaff WW; Howard RJ; Parris CJ; Patton PR; Karlix JL
Clin Transplant; 1995 Jun; 9(3 Pt 1):185-9. PubMed ID: 7549058
[TBL] [Abstract][Full Text] [Related]
5. A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.
Etienne I; Toupance O; Bénichou J; Thierry A; Al Najjar A; Hurault de Ligny B; Le Meur Y; Westeel PF; Marquet P; François A; Hellot MF; Godin M
Nephrol Dial Transplant; 2010 Sep; 25(9):3096-106. PubMed ID: 20299336
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
[TBL] [Abstract][Full Text] [Related]
8. Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients.
Nawaz SH; Zafar MN; Naqvi SA; Rizvi SA
J Pak Med Assoc; 2005 Mar; 55(3):98-100. PubMed ID: 15852743
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran.
Monfared A; Azimi SZ; Kazemnezhad E; Khosravi M; Lebadi M; Mirzajani E; Ashtiani MN
Transplantation; 2014 Jul; 98(1):66-71. PubMed ID: 24978036
[TBL] [Abstract][Full Text] [Related]
10. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
[TBL] [Abstract][Full Text] [Related]
11. A trial of oral magnesium supplementation in renal transplant recipients receiving cyclosporine.
Nguyen T; Steiner RW
Transplant Proc; 1998 Dec; 30(8):4317-9. PubMed ID: 9865371
[No Abstract] [Full Text] [Related]
12. Long-term calcineurin inhibition and magnesium balance after renal transplantation.
Mazzola BL; Vannini SD; Truttmann AC; von Vigier RO; Wermuth B; Ferrari P; Bianchetti MG
Transpl Int; 2003 Feb; 16(2):76-81. PubMed ID: 12595968
[TBL] [Abstract][Full Text] [Related]
13. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
[TBL] [Abstract][Full Text] [Related]
14. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
15. Magnesium loss in cyclosporine-treated patients is related to renal epidermal growth factor downregulation.
Ledeganck KJ; De Winter BY; Van den Driessche A; Jürgens A; Bosmans JL; Couttenye MM; Verpooten GA
Nephrol Dial Transplant; 2014 May; 29(5):1097-102. PubMed ID: 24353324
[TBL] [Abstract][Full Text] [Related]
16. Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine.
Vannini SD; Mazzola BL; Rodoni L; Truttmann AC; Wermuth B; Bianchetti MG; Ferrari P
Transpl Int; 1999; 12(4):244-9. PubMed ID: 10460868
[TBL] [Abstract][Full Text] [Related]
17. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
Song J; Kim MG; Choi B; Han NY; Yun HY; Yoon JH; Oh JM
Ann Pharmacother; 2012 Sep; 46(9):1141-51. PubMed ID: 22947591
[TBL] [Abstract][Full Text] [Related]
18. New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.
Sinangil A; Celik V; Barlas S; Sakaci T; Koc Y; Basturk T; Akin EB; Ecder T
Prog Transplant; 2016 Mar; 26(1):55-61. PubMed ID: 27136250
[TBL] [Abstract][Full Text] [Related]
19. Early short-term profile of serum magnesium concentration in living donor renal transplant recipients on cyclosporine.
Kim HJ; Ahn YH; Kee CS; Lee KS; Kwak JY
Transplant Proc; 1994 Aug; 26(4):2178-80. PubMed ID: 8066713
[No Abstract] [Full Text] [Related]
20. Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.
Pourfarziani V; Taheri S
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):991-4. PubMed ID: 19861858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]